Beta Technologies executed the first operational flights under the FAA and DOT eVTOL Integration Pilot Program on 10 July 2026, transporting manufactured organs between Virginia and Maryland using its all-electric Alia CX300 CTOL aircraft[2][12]. The 275-nautical-mile mission, conducted under Other Transaction Authority, validated time-sensitive medical logistics capabilities without passengers, marking the sector’s shift from regulatory evaluation to routine cargo operations[2][5]. Partnering with United Therapeutics, Beta tested the logistics pipeline for genetically modified pig hearts not yet commercially available for transplant, reinforcing a strategic alliance aimed at future commercial organ delivery once certification is achieved[2][5]. The CX300, with a 337-nautical-mile range and 153-knot top speed, precedes passenger operations planned for the vertical-takeoff A250 model expected to certify in 2028[4][5].